IndraLab
Statements
sparser
"Absence of RAS expression abrogated ERK activation by BRAF F247L and R558Q but had no effect on ERK activation by BRAF L485F and L525R. Based on these data, BRAF A33T was considered to have no effect on ERK signaling, BRAF F247L and R558Q were classified as class 3 mutants, and BRAF L525R and L485F were classified as class 2 mutants."
reach
"The syndrome is caused by gain-of-function mutations in four different genes BRAF, KRAS, mitogen activated protein and extracellular signal regulated kinase MEK1 and MEK2, all belonging to the same RAS-extracellular signal regulated kinase (ERK) pathway that regulates cell differentiation, proliferation and apoptosis."
reach
"XREF_BIBR This genetic alteration of BRAF sequentially induces constitutive extracellular signal regulated kinase (ERK) signaling through a hyperactivation of the RAS/RAF/mitogen activated protein kinase and ERK (MAPK and ERK) pathway that is involved in promoting the proliferation, survival and development of tumor cells."
reach
"One was the highly aggressive triple negative (ER -, PR - and HER2 -) MDA-MB231 cell line, which carries oncogenic mutations in KRAS and BRAF genes, shows enhanced PKCtheta activity and accumulates high levels of Fra-1 as a result of stabilizing phosphorylations by both KRAS- and BRAF activated Erk pathway kinases and PKCtheta."
reach
"Dabrafenib, an inhibitor of RAF-1 and B-RAF, suppressed the early activation of ERK, but a significant amount of phosphorylated ERK remained after 60min of shaking in the presence of dabrafenib (XREF_FIG A), which gradually increased over time only when FSS was applied (XREF_FIG C)."
reach
"Our results suggest that : (i) extracellular signal regulated kinase is activated by B-Raf in response to a calcium sensitive adenylate cyclase; and (ii) extracellular signal regulated kinase activates casein kinase-2 via a protein phosphatase (s) that may be of the PP1 and/or PP2A type."
reach
"The study suggests that multiple factors contribute to the transition and maintenance of the IDTC state and from these observations it is tempting to speculate that the burden of signaling is distributed between multiple pathways unlike the parental BRAF mutant cells, which seem to be primarily dependent on BRAF driven ERK signaling."
sparser
"For instance, increased cell invasion can be mediated by the BRAF mutation-induced activation of phosphorylated extracellular-signal-regulated kinase (pERK), phosphorylated mitogen-activated protein kinase (pMEK), nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), and metalloproteinases activity [ xref ]."
| PMC
reach
"Conversely, ERK-nKTR is excluded from the nuclei of all VPCs when MPK-1 and ERK is activated by uniform expression of a highly active and stable form of LIN-45 and Braf in all VPCs (transgene arTi31, see STAR Methods), (XREF_FIG), similar to the phospho-mimetic ERK-nKTR (EEE) (XREF_FIG)."
reach
"Using a panel of melanoma cell lines derived from the establishment of excised primary and metastatic tumours, we have investigated the ability of dabrafenib to both exert an antiproliferative activity on cultured melanoma cells and block the ERK signalling induced by the mutated BRAF."
reach
"This may result from mutational activation of components of the downstream signaling pathways, such as PIK3CA or BRAF, that directly activate the PI3K and AKT and MEK and ERK pathways, respectively, or activation of another RTK that sustains downstream signaling despite inhibition of the oncogenic RTK."
sparser
"TMRM and calcein-AM staining showed that opening of the mitochondrial permeability transition pore (mPTP) during STS-induced cell death could be significantly inhibited by BRAF V600E. Moreover, our study demonstrated that BRAF V600E constitutively activates mitochondrial ERK (mERK) to inhibit GSK-3-dependent CypD phosphorylation, thereby making BRAF V600E mutant tumour cells more resistant to mPTP opening."
reach
"With respect to BRAF inhibitors, the observation that BRAF selective agents activate ERK signaling in non-BRAF-mutated tumors raises the concern that not only would these agents not be effective in CS or CFC, but they may be contraindicated in non oncology settings by promoting the growth of keratoacanthoma skin lesions."
reach
"Using this vector in a murine syngeneic BM transplantation model for BCR-ABL-induced chronic myeloid leukemia, we find that oncogene expression and target knockdown in primary hematopoietic cells with this vector is efficient both in vitro and in vivo, and demonstrate that Raf1, but not BRAF, modulates BCR-ABL-dependent ERK activation and transformation of hematopoietic cells."
reach
"[XREF_BIBR] The syndrome is caused by gain-of-function mutations in four different genes BRAF, KRAS, mitogen activated protein and extracellular signal regulated kinase MEK1 and MEK2, all belonging to the same RAS extracellular signal regulated kinase (ERK) pathway that regulates cell differentiation, proliferation and apoptosis."
reach
"In a majority of human cancers, the PI3K and AKT pathway is frequently activated by the activating mutations of PI3K p110alpha (PIK3CA) and the loss or inactivating mutation of PTEN, whereas hyper activation of MEK and ERK signaling driven by mutant RAS and BRAF is also a common oncogenic event in a variety of cancers [XREF_BIBR, XREF_BIBR]."
reach
"In melanoma cells harboring the NRAS mutation, the mutated NRAS protein needs CRAF to activate the MEK and ERK pathway XREF_BIBR, and the BRAF protein is phosphorylated by ERK on S151 near the RAS binding domain, which results in the inhibition of the NRAS and BRAF interaction XREF_BIBR."
reach
"c-Raf is thought to be responsible for the transient activation of the ERK pathway required for proliferation upon epidermal growth factor stimulation, while B-Raf causes a persistent activation of ERK required for differentiation in response to stimulation with nerve growth factor [XREF_BIBR], consistent with our observations."
reach
"This pathway is driven by hypermethylation of genes and is characterized by the presence of protooncogene BRAF (protein kinase B-Raf), which causes increased MAPKs and ERKs (mitogen activated protein kinases and extracellular signal regulated kinases) signaling, leading to increased cell proliferation, cell division, and secretion [XREF_BIBR]."
reach
"Indeed, the oncogenic activation of BRAF drives the inappropriate activation of ERK signaling and the deregulation of cell proliferation [XREF_BIBR], and is responsible for the inhibition of the mitochondrial apoptotic pathway [XREF_BIBR - XREF_BIBR], the latter being consistent with the apoptosis resistant phenotype of BRAF driven cancer cells."
sparser
"Interestingly, Vemurafenib treatment increased both the intrinsic kinase activity of endogenous ARAF ( xref ) and ERK activation ( xref ) in double BRAF- and CRAF-deficient resistant cultures, demonstrating that ARAF homodimers are sufficient to sustain ERK paradoxical activation by BRAF inhibitor in the absence of other RAF proteins."
reach
"Available data suggest that the most frequent mutational events in these carcinomas are mutations in B-RAF, leading to activation of the RAF and MEK (mitogen activated protein and extracellular signal regulated kinase (ERK) kinase)/ERK pathway and in phosphoinositide 3-kinase (PI3K)/AKT signalling."
reach
"6 Unfortunately, first and second generation BRAFi can not be used as single agents to treat NRAS-mutant melanoma because while these inhibitors are effective at shutting down ERK signaling mediated by mutant-BRAF, they paradoxically upregulate ERK activity in the presence of oncogenic RAS, by stimulating BRAF-CRAF heterodimerization."
sparser
"► BRAF activates ERK but in some circumstances BRAF inhibitors can induce tumor growth ► BRAF inhibitors drive BRAF-CRAF binding, activating ERK in cells with oncogenic RAS ► Kinase-dead mutants of BRAF have the same effect as BRAF inhibitors ► Oncogenic RAS and kinase-dead BRAF cooperate to induce melanoma in mice"
sparser
"These included B-RAF which activates ERK via MEK1/2 directing cell proliferation, as well as MLK-like mitogen-activated protein triple kinase (MLTK) which can activate JNK-mediated pathway regulating actin organization, and has been shown to be an upstream MAP3K in stress induced by the ribotoxinsanisomycin, ricin and Shiga toxin ( xref ; xref )."
reach
"The identification of BRAF driver mutations in melanoma has led to the development of specific inhibitors targeting the extracellular-signal-regulated kinase (ERK) pathway, which have high response rates and improve survival in patients with BRAF-mutant advanced melanoma and those at high risk of recurrence XREF_BIBR, XREF_BIBR, XREF_BIBR, XREF_BIBR."
reach
"The increased apoptosis, observed in human melanoma cell lines when BRAF expression is downregulated using RNA interference, supports a role for oncogenic BRAF driven MEK and ERK overactivation in maintaining the transformed phenotype of malignant melanoma cells (Hingorani et al, 2003; Karasarides et al, 2004)."
reach
"Direct ERK1/2 inhibition is considered a promising approach to avoid ERK1/2 reactivation caused by upstream kinases BRAF, MEK1/2, and KRAS, as well as by receptor tyrosine kinase inhibitors, but the dynamics and selectivity of ERK1/2 inhibitors are much less studied compared to BRAF or MEK inhibitors."